IL-10 gene therapy prevents TNBS-induced colitis (Q44233130)

1 December 2017

IL-10 gene therapy prevents TNBS-induced colitis (English)

1 reference

1 December 2017

0 references

Lindsay J

1

1 reference

1 December 2017

Van Montfrans C

2

1 reference

1 December 2017

Brennan F

3

1 reference

1 December 2017

Van Deventer S

4

1 reference

1 December 2017

Drillenburg P

5

1 reference

1 December 2017

Hodgson H

6

1 reference

1 December 2017

Te Velde A

7

1 reference

1 December 2017

Sol Rodriguez Pena M

8

1 reference

1 December 2017

1 December 2002

1 reference

1 December 2017

1 reference

1 December 2017

9

1 reference

1 December 2017

24

1 reference

1 December 2017

1715-1721

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301841

1 December 2017

0 references

cites work

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Interleukin-10 and the interleukin-10 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Chronic colitis in IL-10-/- mice: insufficient counter regulation of a Th1 response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

In vivo and in vitro gene transfer and expression in rat intestinal epithelial cells by E1-deleted adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Adenovirus-mediated transduction of intestinal cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

TNF-alpha receptor signaling and IL-10 gene therapy regulate the innate and humoral immune responses to recombinant adenovirus in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Interleukin 10 gene transfer prevents experimental colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

In vitro and in vivo assessment of adenovirus 41 as a vector for gene delivery to the intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Methods for construction of adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

Subtherapeutic corticosteroids potentiate the ability of interleukin 10 to prevent chronic inflammation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

7 January 2021

Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

7 January 2021

Anti-inflammatory properties of interleukin-10 administration in hapten-induced colitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

7 January 2021

Effect of IL-12 and antibodies to IL-12 on established granulomatous colitis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

7 January 2021

Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

7 January 2021

Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301841

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301841

1 reference

1 December 2017

1 reference